Begin main content

Evolocumab

Last Updated: June 4, 2015
Result type: Reports
Project Number: SR0441-000
Product Line: Common Drug Review

Generic Name: Evolocumab

Brand Name: Repatha

Manufacturer: Amgen Canada Inc.

Indications: Primary hyperlipidemia and mixed dyslipidemia

Submission Type: New

Project Status: Complete

Date Recommendation Issued: February 19, 2016

Recommendation Type: List with clinical criteria and/or conditions